Abstract
Toll-like receptors (TLRs) are key components for the recognition of microorganisms, for the initiation of innate immunity, and for promoting adaptive immune responses. TLR signaling in B cells, in addition to B cell receptor or CD40 ligation, plays an important role in B cell differentiation and activation. In contrast, various infectious agents and/or TLR ligands can also prime B cells to induce tolerance and downregulate inflammatory reactions; those B cells are called regulatory B (Breg) cells and are characterized by a dominant IL-10 production. Several studies have suggested that Breg cells are impaired in patients with autoimmune diseases and allergic asthma. However, the role for TLR ligands in the induction of Breg cells as a potential therapy for some of these inflammatory diseases has not yet been investigated. Here, we provide detailed instructions on how to analyze and validate cytokine production in human and mouse B cells in response to various TLR ligands. Furthermore, we describe an assay to investigate the suppressive properties of TLR-induced B cells to confirm their regulatory B cell status.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Fillatreau S, Sweenie CH, McGeachy MJ et al (2002) B cells regulate autoimmunity by provision of IL-10. Nat Immunol 3:944–950
Mauri C, Ehrenstein MR (2008) The ‘short’ history of regulatory B cells. Trends Immunol 29:34–40
Blair PA, Chavez-Rueda KA, Evans JG et al (2009) Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J Immunol 182:3492–3502
Kala M, Rhodes SN, Piao WH et al (2010) B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis. Exp Neurol 221:136–145
Lampropoulou V, Calderon-Gomez E, Roch T et al (2010) Suppressive functions of activated B cells in autoimmune diseases reveal the dual roles of Toll-like receptors in immunity. Immunol Rev 233:146–161
Yang M, Sun L, Wang S et al (2010) Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells. J Immunol 184:3321–3325
Yehudai D, Snir A, Peri R et al (2012) B cell-activating factor enhances interleukin-6 and interleukin-10 production by ODN-activated human B cells. Scand J Immunol 76:371–377
Neves P, Lampropoulou V, Calderon-Gomez E et al (2010) Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection. Immunity 33:777–790
Sayi A, Kohler E, Toller IM et al (2011) TLR-2-activated B cells suppress Helicobacter-induced preneoplastic gastric immunopathology by inducing T regulatory-1 cells. J Immunol 186:878–890
Barr TA, Brown S, Ryan G et al (2007) TLR-mediated stimulation of APC: Distinct cytokine responses of B cells and dendritic cells. Eur J Immunol 37:3040–3053
Bouaziz JD, Calbo S, Maho-Vaillant M et al (2010) IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro. Eur J Immunol 40:2686–2691
Tian J, Zekzer D, Hanssen L et al (2001) Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J Immunol 167:1081–1089
Palanivel V, Posey C, Horauf AM et al (1996) B-cell outgrowth and ligand-specific production of IL-10 correlate with Th2 dominance in certain parasitic diseases. Exp Parasitol 84:168–177
Ronet C, Hauyon-La TY, Revaz-Breton M et al (2010) Regulatory B cells shape the development of Th2 immune responses in BALB/c mice infected with Leishmania major through IL-10 production. J Immunol 184:886–894
Velupillai P, Harn DA (1994) Oligosaccharide-specific induction of interleukin 10 production by B220+ cells from schistosome-infected mice: a mechanism for regulation of CD4+ T-cell subsets. Proc Natl Acad Sci U S A 91:18–22
Lenert P, Brummel R, Field EH et al (2005) TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production. J Clin Immunol 25:29–40
Miyazaki D, Kuo CH, Tominaga T et al (2009) Regulatory function of CpG-activated B cells in late-phase experimental allergic conjunctivitis. Invest Ophthalmol Vis Sci 50:1626–1635
Noh J, Lee JH, Noh G et al (2010) Characterisation of allergen-specific responses of IL-10-producing regulatory B cells (Br1) in Cow Milk Allergy. Cell Immunol 264:143–149
Blair PA, Norena LY, Flores-Borja F et al (2010) CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 32:129–140
Iwata Y, Matsushita T, Horikawa M et al (2011) Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 117:530–541
Flores-Borja F, Bosma A, Ng D et al (2013) CD19 + CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci Transl Med 5:173ra23
van der Vlugt LE, Labuda LA, Ozir-Fazalalikhan A et al (2012) Schistosomes induce regulatory features in human and mouse CD1d(hi) B cells: inhibition of allergic inflammation by IL-10 and regulatory T cells. PLoS One 7:e30883
van der Vlugt LE, Mlejnek E, Ozir-Fazalalikhan A et al (2014) CD24hiCD27+ B cells from allergic asthma patients have impaired regulatory activity in response to LPS. Clin Exp Allergy 44(4):517–528
Hirotani M, Niino M, Fukazawa T et al (2010) Decreased IL-10 production mediated by Toll-like receptor 9 in B cells in multiple sclerosis. J Neuroimmunol 221:95–100
Li X, Zhong H, Bao W et al (2012) Defective regulatory B-cell compartment in patients with immune thrombocytopenia. Blood 120:3318–3325
Hornung V, Rothenfusser S, Britsch S et al (2002) Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 168:4531–4537
Jagannathan M, Hasturk H, Liang Y et al (2009) TLR cross-talk specifically regulates cytokine production by B cells from chronic inflammatory disease patients. J Immunol 183:7461–7470
Shin H, Zhang Y, Jagannathan M et al (2009) B cells from periodontal disease patients express surface Toll-like receptor 4. J Leukoc Biol 85:648–655
Ganley-Leal LM, Liang Y, Jagannathan-Bogdan M et al (2010) Differential regulation of TLR4 expression in human B cells and monocytes. Mol Immunol 48:82–88
McDonnell M, Liang Y, Noronha A et al (2011) Systemic Toll-like receptor ligands modify B-cell responses in human inflammatory bowel disease. Inflamm Bowel Dis 17:298–307
Tsai JJ, Liu SH, Yin SC et al (2011) Mite allergen Der-p2 triggers human B lymphocyte activation and Toll-like receptor-4 induction. PLoS One 6:e23249
Das A, Ellis G, Pallant C et al (2012) IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection. J Immunol 189:3925–3935
Zhang M, Zheng X, Zhang J et al (2012) CD19(+)CD1d(+)CD5(+) B cell frequencies are increased in patients with tuberculosis and suppress Th17 responses. Cell Immunol 274:89–97
Agrawal S, Gupta S (2011) TLR1/2, TLR7, and TLR9 signals directly activate human peripheral blood naive and memory B cell subsets to produce cytokines, chemokines, and hematopoietic growth factors. J Clin Immunol 31:89–98
Correale J, Farez M (2009) Helminth antigens modulate immune responses in cells from multiple sclerosis patients through TLR2-dependent mechanisms. J Immunol 183:5999–6012
van de Veen W, Stanic B, Yaman G et al (2013) IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses. J Allergy Clin Immunol 131:1204–1212
Mizoguchi A, Bhan AK (2006) A case for regulatory B cells. J Immunol 176:705–710
Dilillo DJ, Matsushita T, Tedder TF (2010) B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann NY Acad Sci 1183:38–57
Fillatreau S, Gray D, Anderton SM (2008) Not always the bad guys: B cells as regulators of autoimmune pathology. Nat Rev Immunol 8:391–397
Hartmann G, Krieg AM (2000) Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J Immunol 164:944–953
Jiang W, Lederman MM, Harding CV et al (2007) TLR9 stimulation drives naive B cells to proliferate and to attain enhanced antigen presenting function. Eur J Immunol 37:2205–2213
Krieg AM, Yi AK, Matson S et al (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374:546–549
Barr TA, Shen P, Brown S et al (2012) B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J Exp Med 209:1001–1010
Jin G, Hamaguchi Y, Matsushita T et al (2013) B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells. J Allergy Clin Immunol 131:1674–1682
Burdin N, Rousset F, Banchereau J (1997) B-cell-derived IL-10: production and function. Methods 11:98–111
Roederer M (2001) Spectral compensation for flow cytometry: visualization artifacts, limitations, and caveats. Cytometry 45:194–205
Herzenberg LA, Tung J, Moore WA et al (2006) Interpreting flow cytometry data: a guide for the perplexed. Nat Immunol 7:681–685
Maecker HT, Trotter J (2006) Flow cytometry controls, instrument setup, and the determination of positivity. Cytometry A 69:1037–1042
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
van der Vlugt, L.E.P.M., Haeberlein, S., de Graaf, W., Martha, T.E.D., Smits, H.H. (2014). Toll-Like Receptor Ligation for the Induction of Regulatory B Cells. In: Vitale, G., Mion, F. (eds) Regulatory B Cells. Methods in Molecular Biology, vol 1190. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1161-5_10
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1161-5_10
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1160-8
Online ISBN: 978-1-4939-1161-5
eBook Packages: Springer Protocols